Litcius/Paper detail

A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide

Kaori Sato, Naoto Watamura, Ryo Fujioka, Naomi Mihira, Misaki Sekiguchi, Kenichi Nagata, Toshio Ohshima, Takashi Saito, Takaomi C. Saido, Hiroki Sasaguri

2021Journal of Biological Chemistry40 citationsDOIOpen Access PDF

Abstract

mice and will help accelerate the development of disease-modifying therapies to treat preclinical AD.

Topics & Concepts

NeuroinflammationPSEN1PresenilinBiologyMutationAmyloid (mycology)PathologyGene knockinMutantDiseaseImmunologyAlzheimer's diseaseMedicineCancer researchInflammationGeneGeneticsAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsCholinesterase and Neurodegenerative Diseases
A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide | Litcius